5+ day, 1+ hour ago   (369+ words) Hepatocellular carcinoma is the sixth most common malignancy and the third leading cause of cancer-related death globally. New integrated framework advances precision surgery for liver cancer Hepatocellular carcinoma is the sixth most common malignancy and the third leading cause of…...

1+ week, 5+ day ago   (385+ words) The Clinical Trial Vanguard Elevar Presents Age-Stratified Camrelizumab-Rivoceranib Data After FDA Rejection Two Complete Response Letters from the FDA in roughly two years should have quieted the camrelizumab-rivoceranib story, but Elevar Therapeutics is betting that a granular post hoc cut…...

2+ week, 7+ hour ago   (309+ words) Under a partnership with Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), Alvotech is responsible for the development and manufacturing of AVT80, while Teva is responsible for commercialization. “FDA’s acceptance for review of our BLA for AVT80 is another important milestone for…...

2+ week, 2+ day ago   (843+ words) A correction published in CVIR Oncology has updated the competing-interests declaration attached to a review of pressure modification during hepatic tumor embolization. The notice concerns the article “Pressure modification during hepatic tumor embolization: principles, mechanism of action, and current evidence,…...

2+ week, 5+ day ago   (129+ words) Credit: Chinese Medical Journal To address this, we investigated the mechanisms by which the genetic predisposition and expression of PAI-1 influence Ct-HBx-induced hepatocarcinogenesis and to identify novel predictive and prognostic biomarkers for HBV-HCC. The comprehensive study combined mechanistic experiments in…...

2+ week, 6+ day ago   (719+ words) The study, titled “Liver resection after atezolizumab and bevacizumab versus maintenance therapy for locally advanced hepatocellular carcinoma (TALENTOP): a multicentre, open-label, randomised, phase 3 trial,” was published on August 22, 2026, in The Lancet. Authors: Hui-Chuan Sun, Xiao-Dong Zhu, Feng Shen, Tian-Qiang Song,…...

3+ week, 4+ day ago   (460+ words) New Delhi: A group of 20 North American liver cancer specialists led by an Indian-origin scientist, Dr Amit G Singal, has developed a new framework to decide how liver cancer should be treated. The framework, titled BEACON-HCC — Best Evidence and North…...